Ekso Bionics (EKSO) Competitors $0.47 -0.02 (-4.10%) As of 02:44 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EKSO vs. TPIC, FTEK, SHMD, TRSG, LBGJ, TRT, CVV, GTEC, ZOOZ, and INLFShould you be buying Ekso Bionics stock or one of its competitors? The main competitors of Ekso Bionics include TPI Composites (TPIC), Fuel Tech (FTEK), SCHMID Group (SHMD), Tungray Technologies (TRSG), Li Bang International (LBGJ), Trio-Tech International (TRT), CVD Equipment (CVV), Greenland Technologies (GTEC), ZOOZ Power (ZOOZ), and INLIF (INLF). These companies are all part of the "machinery" industry. Ekso Bionics vs. TPI Composites Fuel Tech SCHMID Group Tungray Technologies Li Bang International Trio-Tech International CVD Equipment Greenland Technologies ZOOZ Power INLIF Ekso Bionics (NASDAQ:EKSO) and TPI Composites (NASDAQ:TPIC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, community ranking, analyst recommendations, media sentiment, profitability, institutional ownership and risk. Is EKSO or TPIC more profitable? TPI Composites has a net margin of -18.01% compared to Ekso Bionics' net margin of -62.95%. TPI Composites' return on equity of 0.00% beat Ekso Bionics' return on equity.Company Net Margins Return on Equity Return on Assets Ekso Bionics-62.95% -83.09% -39.03% TPI Composites -18.01%N/A -25.70% Do analysts rate EKSO or TPIC? Ekso Bionics presently has a consensus price target of $5.00, suggesting a potential upside of 941.88%. TPI Composites has a consensus price target of $3.19, suggesting a potential upside of 262.10%. Given Ekso Bionics' stronger consensus rating and higher probable upside, analysts plainly believe Ekso Bionics is more favorable than TPI Composites.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ekso Bionics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00TPI Composites 2 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.13 Does the media prefer EKSO or TPIC? In the previous week, Ekso Bionics had 5 more articles in the media than TPI Composites. MarketBeat recorded 6 mentions for Ekso Bionics and 1 mentions for TPI Composites. TPI Composites' average media sentiment score of 1.69 beat Ekso Bionics' score of 0.41 indicating that TPI Composites is being referred to more favorably in the news media. Company Overall Sentiment Ekso Bionics Neutral TPI Composites Very Positive Which has more volatility and risk, EKSO or TPIC? Ekso Bionics has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Comparatively, TPI Composites has a beta of 2.06, indicating that its share price is 106% more volatile than the S&P 500. Does the MarketBeat Community prefer EKSO or TPIC? TPI Composites received 31 more outperform votes than Ekso Bionics when rated by MarketBeat users. Likewise, 63.69% of users gave TPI Composites an outperform vote while only 54.08% of users gave Ekso Bionics an outperform vote. CompanyUnderperformOutperformEkso BionicsOutperform Votes32554.08% Underperform Votes27645.92% TPI CompositesOutperform Votes35663.69% Underperform Votes20336.31% Do institutionals and insiders hold more shares of EKSO or TPIC? 6.4% of Ekso Bionics shares are owned by institutional investors. Comparatively, 75.2% of TPI Composites shares are owned by institutional investors. 6.1% of Ekso Bionics shares are owned by insiders. Comparatively, 3.7% of TPI Composites shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has better valuation & earnings, EKSO or TPIC? Ekso Bionics has higher earnings, but lower revenue than TPI Composites. Ekso Bionics is trading at a lower price-to-earnings ratio than TPI Composites, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEkso Bionics$17.93M0.78-$15.20M-$0.57-0.84TPI Composites$1.33B0.03-$201.78M-$5.07-0.17 SummaryTPI Composites beats Ekso Bionics on 11 of the 19 factors compared between the two stocks. Get Ekso Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EKSO vs. The Competition Export to ExcelMetricEkso BionicsGeneral industrial machinery, IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.93M$3.32B$5.53B$7.73BDividend YieldN/A1.10%5.11%4.22%P/E Ratio-0.7415.1122.4318.38Price / Sales0.7810.11392.01103.07Price / CashN/A171.2338.1834.62Price / Book0.565.606.704.21Net Income-$15.20M$39.72M$3.22B$248.14M7 Day Performance14.34%4.37%2.32%2.54%1 Month Performance9.82%-0.64%-0.83%1.02%1 Year Performance-61.30%46.07%17.58%4.92% Ekso Bionics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EKSOEkso Bionics2.9635 of 5 stars$0.47-4.1%$5.00+962.5%-62.0%$13.66M$17.93M-0.7260Upcoming EarningsAnalyst ForecastShort Interest ↓News CoverageTPICTPI Composites4.1848 of 5 stars$0.75+2.8%$3.19+327.4%-71.1%$35.48M$1.33B-0.1513,500Positive NewsFTEKFuel Tech2.7528 of 5 stars$0.99+1.6%$4.00+304.0%-23.7%$29.92M$25.13M-49.5070Upcoming EarningsAnalyst ForecastNews CoverageSHMDSCHMID GroupN/A$2.93+0.7%N/AN/A$29.67M$79.49M0.00800Short Interest ↑TRSGTungray TechnologiesN/A$1.59+0.5%N/A-75.3%$25.71M$14.44M0.00N/AGap UpLBGJLi Bang InternationalN/A$1.22-2.8%N/AN/A$22.50M$10.79M0.00N/APositive NewsTRTTrio-Tech InternationalN/A$4.97-2.4%N/A-22.3%$21.13M$38.56M35.50740Analyst ForecastNews CoverageGap DownCVVCVD Equipment1.7685 of 5 stars$2.96-3.6%N/A-33.1%$21.13M$26.88M-4.70110Analyst ForecastGTECGreenland Technologies2.5234 of 5 stars$1.42-2.7%N/A+14.5%$19.31M$83.94M-1.49330Short Interest ↓News CoveragePositive NewsZOOZZOOZ Power3.1218 of 5 stars$1.46-5.8%$5.00+242.5%-41.8%$17.62M$1.04M0.0050Positive NewsGap DownINLFINLIFN/A$1.21-4.0%N/AN/A$17.55M$14.52M0.00124News Coverage Related Companies and Tools Related Companies TPIC Alternatives FTEK Alternatives SHMD Alternatives TRSG Alternatives LBGJ Alternatives TRT Alternatives CVV Alternatives GTEC Alternatives ZOOZ Alternatives INLF Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EKSO) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredThe Worst Year in American Financial History?Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behin...Stansberry Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ekso Bionics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ekso Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.